LifeMD

LFMD · NASDAQ

$2.25−$0.005 (−0.22%)TodayMarket closed · Oct 20, 7:36 PM ET

Prev close $2.25

Latest news

Press releaseSep 22, 5:01 PM ETGlobe Newswire
LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock
Press releaseSep 15, 9:00 AM ETPRNewswire
AT&T Becomes the First and Only Carrier to Offer Free Access to Virtual Healthcare Powered by LifeMD
Press releaseAug 5, 7:45 PM ETGlobe Newswire
UPDATE - LifeMD Reports Second Quarter 2026 Results
Press releaseAug 5, 4:11 PM ETGlobe Newswire
LifeMD Reports Second Quarter 2026 Results
Press releaseJun 23, 8:00 AM ETGlobe Newswire
LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock
Press releaseJun 22, 8:00 AM ETGlobe Newswire
LifeMD Announces Exclusive Collaboration to Launch Direct-to-Patient Self-Pay Program for XYOSTED® (testosterone enanthate) Injection
Press releaseJun 1, 8:05 AM ETGlobe Newswire
LifeMD Appoints Umesh Sripad as Chief Technology Officer
NewsMay 6, 5:03 PM ET
12 Health Care Stocks Moving In Wednesday's After-Market Session
NewsMay 6, 5:03 PM ET
Earnings Scheduled For May 6, 2026
NewsMay 6, 4:10 PM ET
LifeMD Q1 EPS $(0.20) Beats $(0.23) Estimate, Sales $50.163M Beat $48.842M Estimate
Press releaseMay 6, 4:05 PM ETGlobe Newswire
LifeMD Reports First Quarter 2026 Results
NewsApr 21, 1:22 PM ETVandana Singh
Amazon GLP-1 Program Pressures Hims & Hers Stock
Press releaseApr 10, 8:15 AM ETGlobe Newswire
LifeMD® Now Offering Eli Lilly and Company's Foundayo™ (orforglipron), a New GLP-1 Pill for Weight Management
NewsMar 31, 2:35 PM ETVandana Singh
Slash Your Wegovy Costs: Novo Nordisk Reveals First-Ever Subscription Plan
Press releaseMar 31, 8:45 AM ETGlobe Newswire
LifeMD Offers Novo Nordisk's Industry-First Wegovy® Telehealth Subscription Program
Press releaseMar 24, 4:05 PM ETGlobe Newswire
LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock
Press releaseMar 16, 8:00 AM ETGlobe Newswire
LifeMD Appoints Veteran Healthcare Finance Executive as Chief Financial Officer and Expands Leadership Team
NewsMar 9, 5:05 PM ET
12 Health Care Stocks Moving In Monday's After-Market Session
Press releaseMar 9, 4:05 PM ETGlobe Newswire
LifeMD Reports Fourth Quarter and Full Year 2025 Results
NewsMar 6, 11:02 AM ET
Earnings Outlook For LifeMD
Press releaseJan 6, 8:30 AM ETGlobe Newswire
LifeMD Announces Closing of $50 Million Revolving Credit Facility with Citizens Bank, N.A.
NewsJan 5, 12:23 PM ETVandana Singh
Novo Nordisk's Wegovy Weight Loss Pill Hits US Pharmacies With Lower Starting Cost
Press releaseJan 5, 8:05 AM ETGlobe Newswire
LifeMD Expands Collaboration with Novo Nordisk as Recognized Telehealth Partner Offering Newly Approved Wegovy® Pill
Press releaseDec 26, 8:00 AM ETGlobe Newswire
LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock
Press releaseNov 24, 8:00 AM ETGlobe Newswire
LifeMD Recognized by the 2025 Deloitte Technology Fast 500™ and by TIME's America's Growth Leaders of 2026
NewsNov 22, 8:01 AM ET
Benzinga Bulls And Bears: Nvidia, Webull, Netflix — And Tech Stocks Face Worst Sell-Off Since April
NewsNov 19, 1:59 PM ETAvi Kapoor
Eli Lilly To Rally More Than 12%? Here Are 10 Top Analyst Forecasts For Wednesday
NewsNov 18, 4:06 PM ET
12 Health Care Stocks Moving In Tuesday's After-Market Session
NewsNov 18, 12:53 PM ETAvi Kapoor
Nasdaq Down 1%; Medtronic Earnings Top Views
NewsNov 18, 12:06 PM ET
12 Health Care Stocks Moving In Tuesday's Intraday Session
NewsNov 18, 9:55 AM ETAvi Kapoor
Dow Falls Over 300 Points; Home Depot Posts Downbeat Earnings
NewsNov 18, 7:34 AM ETAvi Kapoor
Alphabet To Rally More Than 12%? Here Are 10 Top Analyst Forecasts For Tuesday
NewsNov 18, 7:06 AM ET
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
NewsNov 18, 6:10 AM ETAvi Kapoor
Why Gorilla Technology Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket
Press releaseNov 17, 4:05 PM ETGlobe Newswire
LifeMD Reports Third Quarter 2025 Results
NewsNov 17, 1:01 PM ETVandana Singh
Novo Nordisk Leans Into Affordability Amid Rising Competition
Press releaseNov 17, 8:00 AM ETGlobe Newswire
LifeMD® to Offer Market-Leading Pricing for GLP-1 Medications Wegovy® and Ozempic® in Continued Collaboration with Novo Nordisk

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.

Latest news

LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock

AT&T Becomes the First and Only Carrier to Offer Free Access to Virtual Healthcare Powered by LifeMD

UPDATE - LifeMD Reports Second Quarter 2026 Results

LifeMD Reports Second Quarter 2026 Results

LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock

LifeMD Announces Exclusive Collaboration to Launch Direct-to-Patient Self-Pay Program for XYOSTED® (testosterone enanthate) Injection

LifeMD Appoints Umesh Sripad as Chief Technology Officer

12 Health Care Stocks Moving In Wednesday's After-Market Session

Earnings Scheduled For May 6, 2026

LifeMD Q1 EPS $(0.20) Beats $(0.23) Estimate, Sales $50.163M Beat $48.842M Estimate

LifeMD Reports First Quarter 2026 Results

Amazon GLP-1 Program Pressures Hims & Hers Stock

LifeMD® Now Offering Eli Lilly and Company's Foundayo™ (orforglipron), a New GLP-1 Pill for Weight Management

Slash Your Wegovy Costs: Novo Nordisk Reveals First-Ever Subscription Plan

LifeMD Offers Novo Nordisk's Industry-First Wegovy® Telehealth Subscription Program

LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock

LifeMD Appoints Veteran Healthcare Finance Executive as Chief Financial Officer and Expands Leadership Team

12 Health Care Stocks Moving In Monday's After-Market Session

LifeMD Reports Fourth Quarter and Full Year 2025 Results

Earnings Outlook For LifeMD

LifeMD Announces Closing of $50 Million Revolving Credit Facility with Citizens Bank, N.A.

Novo Nordisk's Wegovy Weight Loss Pill Hits US Pharmacies With Lower Starting Cost

LifeMD Expands Collaboration with Novo Nordisk as Recognized Telehealth Partner Offering Newly Approved Wegovy® Pill

LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock

LifeMD Recognized by the 2025 Deloitte Technology Fast 500™ and by TIME's America's Growth Leaders of 2026

Benzinga Bulls And Bears: Nvidia, Webull, Netflix — And Tech Stocks Face Worst Sell-Off Since April

Eli Lilly To Rally More Than 12%? Here Are 10 Top Analyst Forecasts For Wednesday

12 Health Care Stocks Moving In Tuesday's After-Market Session

Nasdaq Down 1%; Medtronic Earnings Top Views

12 Health Care Stocks Moving In Tuesday's Intraday Session

Dow Falls Over 300 Points; Home Depot Posts Downbeat Earnings

Alphabet To Rally More Than 12%? Here Are 10 Top Analyst Forecasts For Tuesday

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

Why Gorilla Technology Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket

LifeMD Reports Third Quarter 2025 Results

Novo Nordisk Leans Into Affordability Amid Rising Competition

LifeMD® to Offer Market-Leading Pricing for GLP-1 Medications Wegovy® and Ozempic® in Continued Collaboration with Novo Nordisk